• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Acadia Healthcare Company Inc. (Amendment)

    6/6/24 9:54:34 AM ET
    $ACHC
    Medical Specialities
    Health Care
    Get the next $ACHC alert in real time by email
    SC 13G/A 1 SEC13G_Filing.htm SEC SCHEDULE 13G

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934

    (Amendment No. 10 )*

                

    Acadia Healthcare Company, Inc.


    (Name of Issuer)

    Common Stock


    (Title of Class of Securities)

    00404A109


    (CUSIP Number)

    May 31, 2024


    (Date of Event Which Requires Filing of this Statement)

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    [X] Rule 13d-1(b)
    [ ] Rule 13d-1(c)
    [ ] Rule 13d-1(d)

    * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 (the "Act") or otherwise subject to the liabilities of that section of the Act, but shall be subject to all other provisions of the Act (however, see the Notes.)


    CUSIP No. 00404A109

    1. NAMES OF REPORTING PERSONS

    Wellington Management Group LLP
    2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) [ ]
    (b) [ ]
    3. SEC USE ONLY
    4. CITIZENSHIP OR PLACE OF ORGANIZATION

    Massachusetts

    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH

    5. SOLE VOTING POWER 0
    6. SHARED VOTING POWER 9,443,757
    7. SOLE DISPOSITIVE POWER 0
    8. SHARED DISPOSITIVE POWER 10,238,092
    9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    10,238,092
    10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    [ ]
    11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    11.04%
    12. TYPE OF REPORTING PERSON

    HC


    CUSIP No. 00404A109

    1. NAMES OF REPORTING PERSONS

    Wellington Group Holdings LLP
    2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) [ ]
    (b) [ ]
    3. SEC USE ONLY
    4. CITIZENSHIP OR PLACE OF ORGANIZATION

    Delaware

    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH

    5. SOLE VOTING POWER 0
    6. SHARED VOTING POWER 9,443,757
    7. SOLE DISPOSITIVE POWER 0
    8. SHARED DISPOSITIVE POWER 10,238,092
    9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    10,238,092
    10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    [ ]
    11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    11.04%
    12. TYPE OF REPORTING PERSON

    HC


    CUSIP No. 00404A109

    1. NAMES OF REPORTING PERSONS

    Wellington Investment Advisors Holdings LLP
    2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) [ ]
    (b) [ ]
    3. SEC USE ONLY
    4. CITIZENSHIP OR PLACE OF ORGANIZATION

    Delaware

    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH

    5. SOLE VOTING POWER 0
    6. SHARED VOTING POWER 9,443,757
    7. SOLE DISPOSITIVE POWER 0
    8. SHARED DISPOSITIVE POWER 10,238,092
    9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    10,238,092
    10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    [ ]
    11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    11.04%
    12. TYPE OF REPORTING PERSON

    HC


    CUSIP No. 00404A109

    1. NAMES OF REPORTING PERSONS

    Wellington Management Company LLP
    2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) [ ]
    (b) [ ]
    3. SEC USE ONLY
    4. CITIZENSHIP OR PLACE OF ORGANIZATION

    Delaware

    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH

    5. SOLE VOTING POWER 0
    6. SHARED VOTING POWER 9,423,741
    7. SOLE DISPOSITIVE POWER 0
    8. SHARED DISPOSITIVE POWER 9,922,577
    9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    9,922,577
    10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    [ ]
    11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    10.70%
    12. TYPE OF REPORTING PERSON

    IA

    Item 1.
    (a) Name of Issuer
    Acadia Healthcare Company, Inc.
    (b) Address of Issuer's Principal Executive Offices
    6100 Tower Circle
    Suite 1000
    Franklin, TN 37067
    Item 2.
    (a) Name of Person Filing
    Wellington Management Group LLP
    Wellington Group Holdings LLP
    Wellington Investment Advisors Holdings LLP
    Wellington Management Company LLP
    (b) Address of Principal Business Office or, if None, Residence
    c/o Wellington Management Company LLP
    280 Congress Street
    Boston, MA 02210
    (c) Citizenship
    Wellington Management Group LLP - Massachusetts
    Wellington Group Holdings LLP - Delaware
    Wellington Investment Advisors Holdings LLP - Delaware
    Wellington Management Company LLP - Delaware
    (d) Title of Class of Securities
    Common Stock
    (e) CUSIP Number
    00404A109
    Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a:
    (a) [ ] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o).
    (b) [ ] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c).
    (c) [ ] Insurance Company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c).
    (d) [ ] Investment Company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
    (e) [X] An investment adviser in accordance with Rule 240.13d-1(b)(1)(ii)(E); *
    (f) [ ] An employee benefit plan or endowment fund in accordance with Rule 240.13d-1(b)(1)(ii)(F);
    (g) [X] A parent holding company or control person in accordance with Rule 240.13d-1(b)(1)(ii)(G);
    (h) [ ] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i) [ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j) [ ] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(J).
    If this statement is filed pursuant to Rule 13d-1(c), check this box [ ]
    Wellington Management Group LLP - HC
    Wellington Group Holdings LLP - HC
    Wellington Investment Advisors Holdings LLP - HC
    Wellington Management Company LLP - IA
    Item 4. Ownership.
    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
    (a) Amount Beneficially Owned:
    See the responses to Item 9 on the attached cover pages.
    (b) Percent of Class:
    See the responses to Item 11 on the attached cover pages.
    (c) Number of shares as to which such person has:
    (i) sole power to vote or to direct the vote 0
    (ii) shared power to vote or to direct the vote See the responses to Item 6 on the attached cover pages.
    (iii) sole power to dispose or to direct the disposition of 0
    (iv) shared power to dispose or to direct the disposition of See the responses to Item 8 on the attached cover pages.
    Item 5. Ownership of Five Percent or Less of Class.
    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: [ ]
    Item 6. Ownership of More than Five Percent on Behalf of Another Person.
    The securities as to which this Schedule is filed are owned of record by clients of one or more investment advisers identified in Exhibit A directly or indirectly owned by Wellington Management Group LLP. Those clients have the right to receive, or the power to direct the receipt of, dividends from, or the proceeds from the sale of, such securities. No such client is known to have such right or power with respect to more than five percent of this class of securities, except as follows:

    Not Applicable.
    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.

    See attached Exhibit A.
    Item 8. Identification and Classification of Members of the Group.

    Not Applicable.
    Item 9. Notice of Dissolution of Group.

    Not Applicable.
    Item 10. Certification.

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    By: Wellington Management Group LLP
    By: /s/ Taisia Lowe
    Name: Taisia Lowe
    Title: Regulatory Analyst
    Date: June 7, 2024

    By: Wellington Group Holdings LLP
    By: /s/ Taisia Lowe
    Name: Taisia Lowe
    Title: Regulatory Analyst
    Date: June 7, 2024

    By: Wellington Investment Advisors Holdings LLP
    By: /s/ Taisia Lowe
    Name: Taisia Lowe
    Title: Regulatory Analyst
    Date: June 7, 2024

    By: Wellington Management Company LLP
    By: /s/ Taisia Lowe
    Name: Taisia Lowe
    Title: Regulatory Analyst
    Date: June 7, 2024


    Exhibit A

    Pursuant to the instructions in Item 7 of Schedule 13G, the following lists the identity and Item 3 classification of each relevant entity that beneficially owns shares of the security class being reported on this Schedule 13G.

    Wellington Group Holdings LLP – HC
    Wellington Investment Advisors LLP – HC
    Wellington Management Global Holdings, Ltd. - HC

    One or more of the following investment advisers (the “Wellington Investment Advisers”):

    Wellington Management Company LLP – IA
    Wellington Management Canada LLC – IA
    Wellington Management Singapore Pte Ltd – IA
    Wellington Management Hong Kong Ltd – IA
    Wellington Management International Ltd – IA
    Wellington Management Japan Pte Ltd – IA
    Wellington Management Australia Pty Ltd - IA

    The securities as to which this Schedule is filed by Wellington Management Group LLP, as parent holding company of certain holding companies and the Wellington Investment Advisers, are owned of record by clients of the Wellington Investment Advisers. Wellington Investment Advisors Holdings LLP controls directly, or indirectly through Wellington Management Global Holdings, Ltd., the Wellington Investment Advisers. Wellington Investment Advisors Holdings LLP is owned by Wellington Group Holdings LLP. Wellington Group Holdings LLP is owned by Wellington Management Group LLP.


    EXHIBIT B

    JOINT FILING AGREEMENT

    The undersigned hereby agree that this Schedule 13G (the “Schedule 13G”) with respect to the common stock of Acadia Healthcare Company, Inc. is, and any additional amendment thereto signed by each of the undersigned shall be, filed on behalf of each undersigned pursuant to and in accordance with the provisions of 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that all subsequent amendments to the Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the other, except to the extent that it knows or has reason to believe that such information is inaccurate. It is understood and agreed that the joint filing of the Schedule 13G shall not be construed as an admission that the persons named herein constitute a group for purposes of Regulation 13D-G of the Securities Exchange Act of 1934, nor is a joint venture for purposes of the Investment Company Act of 1940.


    By: Wellington Management Group LLP
    By: /s/ Taisia Lowe
    Name: Taisia Lowe
    Title: Regulatory Analyst
    Date: June 7, 2024

    By: Wellington Group Holdings LLP
    By: /s/ Taisia Lowe
    Name: Taisia Lowe
    Title: Regulatory Analyst
    Date: June 7, 2024

    By: Wellington Investment Advisors Holdings LLP
    By: /s/ Taisia Lowe
    Name: Taisia Lowe
    Title: Regulatory Analyst
    Date: June 7, 2024

    By: Wellington Management Company LLP
    By: /s/ Taisia Lowe
    Name: Taisia Lowe
    Title: Regulatory Analyst
    Date: June 7, 2024

    Get the next $ACHC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ACHC

    DatePrice TargetRatingAnalyst
    2/28/2025$43.00 → $35.00Overweight → Equal Weight
    Barclays
    1/7/2025$70.00Sector Weight → Overweight
    KeyBanc Capital Markets
    12/12/2024$45.00 → $75.00Hold → Buy
    Deutsche Bank
    10/11/2024Sector Weight
    KeyBanc Capital Markets
    4/25/2024$70.00Sell → Hold
    Deutsche Bank
    3/6/2024$100.00Overweight
    Barclays
    4/21/2023$83.00Neutral
    Cantor Fitzgerald
    4/20/2023$75.00 → $63.00Hold → Sell
    Deutsche Bank
    More analyst ratings

    $ACHC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Acadia Healthcare Reports First Quarter 2025 Results

      Affirms Full Year 2025 Guidance Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights Revenue totaled $770.5 million, compared with $768.1 million for the first quarter of 2024 Same facility revenue increased 2.1% compared with the first quarter of 2024, including an increase in patient days of 2.2% Same facility revenue and patient day growth both included an unfavorable year-over-year impact from the leap year of approximately 1.1% Net income attributable to Acadia totaled $8.4 million, or $0.09 per diluted share Adjusted income attributable to Acadia

      5/12/25 4:07:00 PM ET
      $ACHC
      Medical Specialities
      Health Care
    • Acadia Healthcare to Participate in BofA Securities Health Care Conference

      Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced that the Company will participate in the BofA Securities 2025 Health Care Conference, May 13-15, 2025, in Las Vegas, Nevada. In connection with the conference, there will be an online webcast of the Company's presentation available on the Company's website starting at 1:20 p.m. Central Time / 11:20 a.m. Pacific Time on Wednesday, May 14th, 2025. The live webcast of the presentation will be available on the Company's website, www.acadiahealthcare.com, by clicking on the "Investors" link. A replay of the presentation will also be available on the Company's website for 30 days. About Acadia Acadia is a leading provider of behavi

      5/8/25 11:00:00 AM ET
      $ACHC
      Medical Specialities
      Health Care
    • Acadia Healthcare Announces Date for First Quarter 2025 Earnings Release

      Acadia Healthcare (NASDAQ:ACHC) ("Acadia" or the "Company") today announced that it will release its first quarter 2025 financial results on Monday, May 12, 2025, after the close of the market. Acadia will conduct a conference call with institutional investors and analysts on Tuesday, May 13, 2025, at 8:30 a.m. ET. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the "Investors" section of the website. The webcast of the conference call will be available for 30 days. The Company also announced that on April 18, 2025, Heather Dixon, the Company's Chief Financial Officer, will take a brief medical leave to recover from a planned medical procedure. Duri

      4/16/25 8:00:00 AM ET
      $ACHC
      Medical Specialities
      Health Care

    $ACHC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Executive Officer Hunter Christopher H. covered exercise/tax liability with 1,889 shares, decreasing direct ownership by 0.71% to 263,994 units (SEC Form 4)

      4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)

      5/13/25 5:01:03 PM ET
      $ACHC
      Medical Specialities
      Health Care
    • Chief Financial Officer Dixon Heather Brianne was granted 43,823 shares, increasing direct ownership by 56% to 122,499 units (SEC Form 4)

      4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)

      5/7/25 6:02:50 PM ET
      $ACHC
      Medical Specialities
      Health Care
    • EVP, GC and Secretary Farley Brian was granted 38,606 shares, increasing direct ownership by 112% to 73,022 units (SEC Form 4)

      4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)

      5/7/25 5:57:46 PM ET
      $ACHC
      Medical Specialities
      Health Care

    $ACHC
    Financials

    Live finance-specific insights

    See more
    • Acadia Healthcare Reports First Quarter 2025 Results

      Affirms Full Year 2025 Guidance Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights Revenue totaled $770.5 million, compared with $768.1 million for the first quarter of 2024 Same facility revenue increased 2.1% compared with the first quarter of 2024, including an increase in patient days of 2.2% Same facility revenue and patient day growth both included an unfavorable year-over-year impact from the leap year of approximately 1.1% Net income attributable to Acadia totaled $8.4 million, or $0.09 per diluted share Adjusted income attributable to Acadia

      5/12/25 4:07:00 PM ET
      $ACHC
      Medical Specialities
      Health Care
    • Acadia Healthcare Announces Date for First Quarter 2025 Earnings Release

      Acadia Healthcare (NASDAQ:ACHC) ("Acadia" or the "Company") today announced that it will release its first quarter 2025 financial results on Monday, May 12, 2025, after the close of the market. Acadia will conduct a conference call with institutional investors and analysts on Tuesday, May 13, 2025, at 8:30 a.m. ET. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the "Investors" section of the website. The webcast of the conference call will be available for 30 days. The Company also announced that on April 18, 2025, Heather Dixon, the Company's Chief Financial Officer, will take a brief medical leave to recover from a planned medical procedure. Duri

      4/16/25 8:00:00 AM ET
      $ACHC
      Medical Specialities
      Health Care
    • Acadia Healthcare Reports Fourth Quarter 2024 Results

      Company Provides Full Year and First Quarter 2025 Guidance, Announces $300 Million Share Repurchase Authorization Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced financial results for the fourth quarter and year ended December 31, 2024. Fourth Quarter 2024 Highlights Revenue totaled $774.2 million, an increase of 4.2% over the fourth quarter of 2023. Same facility revenue increased 4.7% compared with the fourth quarter of 2023, including an increase in patient days of 3.2% and an increase in revenue per patient day of 1.4%. Net income attributable to Acadia totaled $32.6 million, or $0.35 per diluted share. Adjusted income attributab

      2/27/25 4:05:00 PM ET
      $ACHC
      Medical Specialities
      Health Care

    $ACHC
    SEC Filings

    See more
    • Acadia Healthcare Company Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Acadia Healthcare Company, Inc. (0001520697) (Filer)

      5/12/25 4:38:36 PM ET
      $ACHC
      Medical Specialities
      Health Care
    • SEC Form 10-Q filed by Acadia Healthcare Company Inc.

      10-Q - Acadia Healthcare Company, Inc. (0001520697) (Filer)

      5/12/25 4:30:31 PM ET
      $ACHC
      Medical Specialities
      Health Care
    • SEC Form DEFA14A filed by Acadia Healthcare Company Inc.

      DEFA14A - Acadia Healthcare Company, Inc. (0001520697) (Filer)

      4/10/25 5:03:34 PM ET
      $ACHC
      Medical Specialities
      Health Care

    $ACHC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Acadia Healthcare downgraded by Barclays with a new price target

      Barclays downgraded Acadia Healthcare from Overweight to Equal Weight and set a new price target of $35.00 from $43.00 previously

      2/28/25 7:39:54 AM ET
      $ACHC
      Medical Specialities
      Health Care
    • Acadia Healthcare upgraded by KeyBanc Capital Markets with a new price target

      KeyBanc Capital Markets upgraded Acadia Healthcare from Sector Weight to Overweight and set a new price target of $70.00

      1/7/25 7:39:01 AM ET
      $ACHC
      Medical Specialities
      Health Care
    • Acadia Healthcare upgraded by Deutsche Bank with a new price target

      Deutsche Bank upgraded Acadia Healthcare from Hold to Buy and set a new price target of $75.00 from $45.00 previously

      12/12/24 8:38:21 AM ET
      $ACHC
      Medical Specialities
      Health Care

    $ACHC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Acadia Healthcare Company Inc.

      SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)

      11/14/24 1:28:32 PM ET
      $ACHC
      Medical Specialities
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Acadia Healthcare Company Inc.

      SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)

      11/12/24 9:50:14 AM ET
      $ACHC
      Medical Specialities
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Acadia Healthcare Company Inc.

      SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)

      11/8/24 10:52:39 AM ET
      $ACHC
      Medical Specialities
      Health Care

    $ACHC
    Leadership Updates

    Live Leadership Updates

    See more
    • Agave Ridge Behavioral Hospital Hosts Ceremony to Celebrate Grand Opening

      Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced the opening of its newest acute care hospital, Agave Ridge Behavioral Hospital, located at 3322 S. Ellsworth Road, in Mesa, Arizona. A ribbon-cutting ceremony was held today to mark its grand opening. The first patient admissions are expected to follow in the coming days as the hospital completes its final preparations to provide care for those in need. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240411986178/en/Acadia Healthcare hosts ribbon-cutting ceremony on April 11, 2024, for its new behavioral health hospital in Mesa, Arizona. The new hospital, named Agave R

      4/11/24 2:16:00 PM ET
      $ACHC
      Medical Specialities
      Health Care
    • Acadia Healthcare Appoints Dr. Stephanie Eken as Chief Medical Officer

      Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced the appointment of Dr. Stephanie Eken as the Company's new chief medical officer. Dr. Eken is a psychiatrist with more than two decades of experience across the spectrum of behavioral health. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240404108920/en/Acadia Healthcare Appoints Dr. Stephanie Eken as Chief Medical Officer (Photo: Business Wire) "Acadia is thrilled to welcome Dr. Eken as our new chief medical officer," said Chris Hunter, Chief Executive Officer of Acadia Healthcare. "Her experience and expertise will help Acadia set the standard for care across the i

      4/4/24 9:00:00 AM ET
      $ACHC
      Medical Specialities
      Health Care
    • Henry Ford Health and Acadia Healthcare Appoint Emily Sexton as CEO of New Henry Ford Behavioral Health Hospital

      Henry Ford Health, one of the nation's premier academic and integrated health systems, and Acadia Healthcare, the nation's largest stand-alone behavioral healthcare company, today announced the appointment of Emily Sexton as Chief Executive Officer of Henry Ford Behavioral Health Hospital, the new 192-bed inpatient behavioral health hospital being built through a joint venture partnership between Henry Ford and Acadia in West Bloomfield, Michigan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240220715559/en/Henry Ford Health and Acadia Healthcare announced the appointment of Emily Sexton as Chief Executive Officer of Henry For

      2/20/24 1:00:00 PM ET
      $ACHC
      Medical Specialities
      Health Care